DPPG(2)-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer

PURPOSE: Current treatment options for muscle-invasive bladder cancer (MIBC) are associated with substantial morbidity. Local release of doxorubicin (DOX) from phosphatidyldiglycerol-based thermosensitive liposomes (DPPG(2)-TSL-DOX) potentiated by hyperthermia (HT) in the bladder wall may result in...

Descripción completa

Detalles Bibliográficos
Autores principales: van Valenberg, F Johannes P, Brummelhuis, Iris S G, Lindner, Lars H, Kuhnle, Felix, Wedmann, Barbara, Schweizer, Pascal, Hossann, Martin, Witjes, J Alfred, Oosterwijk, Egbert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802347/
https://www.ncbi.nlm.nih.gov/pubmed/33447028
http://dx.doi.org/10.2147/IJN.S280034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802347/
https://www.ncbi.nlm.nih.gov/pubmed/33447028
http://dx.doi.org/10.2147/IJN.S280034

Ejemplares similares